Managers / Q2 2024 · view latest →
PenderFund Capital Management Ltd.
CIK 0001706164 · SUITE 1830, 1066 W. HASTINGS STREET, VANCOUVER, A1, V6E 3X2 · 6046881511
Reported Value
$364M
Q2 2024
Positions
126
Filings on Record
32
2019–present window
Filed
Aug 14, 2024
original filing
Summary
Penderfund Capital Management Ltd. reported $364M in U.S.-listed holdings across 126 positions for Q2 2024.
Its largest position, Esperion Therapeutics Inc Ne, represents 14.3% of the portfolio.
Compared with Q1 2024, the fund opened 51 new positions and exited 41.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- US DOMESTIC · 34.6% · $126M
- Common Stock · 26.0% · $95M
- GLOBAL · 18.6% · $68M
- Closed-End Fund · 9.1% · $33M
- Other · 8.7% · $32M
- Other · 2.9% · $11M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q2 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $639M | 253 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $635M | 219 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $593M | 207 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $367M | 142 | Aug 14, 2025 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2025 | $514M | 142 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $465M | 129 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $434M | 137 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $364M | 126 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $378M | 116 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $307M | 105 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $333,695 | 112 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $321,680 | 114 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $318,441 | 130 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $335M | 140 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $320M | 179 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $362M | 179 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $408M | 172 | May 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $441M | 157 | Feb 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $383M | 140 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $427M | 88 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $412M | 92 | May 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $393M | 81 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $360M | 70 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $370M | 71 | Aug 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $320M | 57 | Apr 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $356M | 56 | Feb 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $297M | 64 | Oct 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $280M | 67 | Jul 31, 2019 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2019 | $344M | 69 | Apr 23, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $302M | 70 | Jan 24, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.